[Metabolic syndrome in patients with gastrointestinal diseases].
OBJECTIVE
To study gastrointestinal pathology in patients with metabolic syndrome (MS).


METHODS
The examination of 536 patients with MS and gastrointestinal diseases included clinical tests, biochemical hepatic tests, determination of blood lipid spectrum, x-ray of the esophagus, stomach, duodenum, colon, esophagogastroduodenoscopy, ultrasonic investigation of the liver, gall bladder and pancreas. 56 patients have undergone puncture biopsy of the liver.


RESULTS
Esophageal, hepatic and biliary, pancreatic, colon diseases were detected in 72, 64, 18 and 74%, respectively. Clinical manifestations of these associated diseases had no definite symptoms and were characterized by cross-over syndromes.


CONCLUSIONS
MS patients with gastrointestinal diseases showed polymorbidity. Treatment of the above diseases should be supplemented with drug correction of MS.
D000273:Adipose Tissue / Q000378:metabolism; D000368:Aged; D004064:Digestive System / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology*; D004066:Digestive System Diseases / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood; D008111:Liver Function Tests; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications / Q000378:metabolism / Q000473:pathology; D008875:Middle Aged; D010186:Pancreatic Function Tests; D014463:Ultrasonography
D008055:Lipids